{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T05:08:30Z","timestamp":1785215310880,"version":"3.55.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T00:00:00Z","timestamp":1660521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T00:00:00Z","timestamp":1660521600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006095","name":"South Eastern Norway Regional Health Authority","doi-asserted-by":"crossref","award":["2016133"],"award-info":[{"award-number":["2016133"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006095","name":"South Eastern Norway Regional Health Authority","doi-asserted-by":"crossref","award":["276940"],"award-info":[{"award-number":["276940"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006095","name":"South Eastern Norway Regional Health Authority","doi-asserted-by":"crossref","award":["2015098"],"award-info":[{"award-number":["2015098"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006095","name":"South Eastern Norway Regional Health Authority","doi-asserted-by":"crossref","award":["276940"],"award-info":[{"award-number":["276940"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005416","name":"Research Council of Norway","doi-asserted-by":"crossref","award":["295910"],"award-info":[{"award-number":["295910"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Aminoacyl tRNA-synthetases are ubiquitously-expressed enzymes that attach amino acids to their cognate tRNA molecules. Mutations in several genes encoding aminoacyl tRNA-synthetases, have been associated with peripheral neuropathy, i.e. <jats:italic>AARS1, GARS1, HARS1, YARS1<\/jats:italic> and <jats:italic>WARS1<\/jats:italic>. The pathogenic mechanism underlying <jats:italic>AARS1<\/jats:italic>-related neuropathy is not known.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>From 2012 onward, all probands presenting at Telemark Hospital (Skien, Norway) with peripheral neuropathy were screened for variants in <jats:italic>AARS1<\/jats:italic> using an \u201cin-house\u201d next-generation sequencing panel. DNA from patient\u2019s family members was examined by Sanger sequencing. Blood from affected family members and healthy controls were used for quantification of <jats:italic>AARS1<\/jats:italic> mRNA and alanine. Proteomic analyses were conducted in peripheral blood mononuclear cells (PBMC) from four affected family members and five healthy controls.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Seventeen individuals in two Norwegian families affected by Charcot-Marie-Tooth disease (CMT) were characterized in this study. The heterozygous NM_001605.2:c.976C\u2009&gt;\u2009T p.(Arg326Trp) <jats:italic>AARS1<\/jats:italic> mutation was identified in ten affected family members. All living carriers had a mild to severe length-dependent sensorimotor neuropathy. Three deceased obligate carriers aged 74\u201398 were reported to be unaffected, but were not examined in the clinic. Proteomic studies in PBMC from four affected individuals suggest an effect on the immune system mediated by components of a systemic response to chronic injury and inflammation. Furthermore, altered expression of proteins linked to mitochondrial function\/dysfunction was observed. Proteomic data are available via ProteomeXchange using identifier PXD023842.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study describes clinical and neurophysiological features linked to the p.(Arg326Trp) variant of <jats:italic>AARS1<\/jats:italic> in CMT-affected members of two Norwegian families. Proteomic analyses based on of PBMC from four CMT-affected individuals suggest that involvement of inflammation and mitochondrial dysfunction might contribute to <jats:italic>AARS1<\/jats:italic> variant-associated peripheral neuropathy.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12883-022-02828-6","type":"journal-article","created":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T09:02:56Z","timestamp":1660554176000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Clinical characteristics and proteome modifications in two Charcot-Marie-Tooth families with the AARS1 Arg326Trp mutation"],"prefix":"10.1186","volume":"22","author":[{"given":"Helle","family":"H\u00f8yer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8yvind L.","family":"Busk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q. Ying.","family":"Esbensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oddveig","family":"R\u00f8sby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilde T.","family":"Hilmarsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuula A.","family":"Nyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geir J.","family":"Braathen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilde L.","family":"Nilsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,15]]},"reference":[{"issue":"R2","key":"2828_CR1","doi-asserted-by":"publisher","first-page":"R114","DOI":"10.1093\/hmg\/ddx231","volume":"26","author":"R Meyer-Schuman","year":"2017","unstructured":"Meyer-Schuman R, Antonellis A. Emerging mechanisms of aminoacyl-tRNA synthetase mutations in recessive and dominant human disease. Hum Mol Genet. 2017;26(R2):R114\u201327.","journal-title":"Hum Mol Genet"},{"issue":"2","key":"2828_CR2","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.tig.2019.11.007","volume":"36","author":"ME Kuo","year":"2020","unstructured":"Kuo ME, Antonellis A. Ubiquitously Expressed Proteins and Restricted Phenotypes: Exploring Cell-Specific Sensitivities to Impaired tRNA Charging. Trends in genetics\u202f: TIG. 2020;36(2):105\u201317.","journal-title":"Trends in genetics : TIG"},{"issue":"14","key":"2828_CR3","doi-asserted-by":"publisher","first-page":"5321","DOI":"10.1074\/jbc.REV118.002955","volume":"294","author":"N Wei","year":"2019","unstructured":"Wei N, Zhang Q, Yang XL. Neurodegenerative Charcot-Marie-Tooth disease as a case study to decipher novel functions of aminoacyl-tRNA synthetases. J Biol Chem. 2019;294(14):5321\u201339.","journal-title":"J Biol Chem"},{"issue":"4\u20135","key":"2828_CR4","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1080\/15476286.2017.1330245","volume":"15","author":"J Ognjenovic","year":"2018","unstructured":"Ognjenovic J, Simonovic M. Human aminoacyl-tRNA synthetases in diseases of the nervous system. RNA Biol. 2018;15(4\u20135):623\u201334.","journal-title":"RNA Biol"},{"issue":"9","key":"2828_CR5","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1002\/bies.201600052","volume":"38","author":"E Storkebaum","year":"2016","unstructured":"Storkebaum E. Peripheral neuropathy via mutant tRNA synthetases: Inhibition of protein translation provides a possible explanation. BioEssays. 2016;38(9):818\u201329.","journal-title":"BioEssays"},{"issue":"1","key":"2828_CR6","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ajhg.2009.12.005","volume":"86","author":"P Latour","year":"2010","unstructured":"Latour P, Thauvin-Robinet C, Baudelet-Mery C, Soichot P, Cusin V, Faivre L, et al. A major determinant for binding and aminoacylation of tRNA(Ala) in cytoplasmic Alanyl-tRNA synthetase is mutated in dominant axonal Charcot-Marie-Tooth disease. Am J Hum Genet. 2010;86(1):77\u201382.","journal-title":"Am J Hum Genet"},{"issue":"5","key":"2828_CR7","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1086\/375039","volume":"72","author":"A Antonellis","year":"2003","unstructured":"Antonellis A, Ellsworth RE, Sambuughin N, Puls I, Abel A, Lee-Lin SQ, et al. Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am J Hum Genet. 2003;72(5):1293\u20139.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"2828_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/humu.22210","volume":"34","author":"A Vester","year":"2013","unstructured":"Vester A, Velez-Ruiz G, McLaughlin HM, Program NCS, Lupski JR, Talbot K, et al. A loss-of-function variant in the human histidyl-tRNA synthetase (HARS) gene is neurotoxic in vivo. Hum Mutat. 2013;34(1):191\u20139.","journal-title":"Hum Mutat"},{"issue":"5","key":"2828_CR9","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1093\/brain\/awx058","volume":"140","author":"PC Tsai","year":"2017","unstructured":"Tsai PC, Soong BW, Mademan I, Huang YH, Liu CR, Hsiao CT, et al. A recurrent WARS mutation is a novel cause of autosomal dominant distal hereditary motor neuropathy. Brain. 2017;140(5):1252\u201366.","journal-title":"Brain"},{"issue":"2","key":"2828_CR10","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/ng1727","volume":"38","author":"A Jordanova","year":"2006","unstructured":"Jordanova A, Irobi J, Thomas FP, Van Dijck P, Meerschaert K, Dewil M, et al. Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy. Nat Genet. 2006;38(2):197\u2013202.","journal-title":"Nat Genet"},{"issue":"11","key":"2828_CR11","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1136\/jnnp-2013-305049","volume":"84","author":"M Gonzalez","year":"2013","unstructured":"Gonzalez M, McLaughlin H, Houlden H, Guo M, Yo-Tsen L, Hadjivassilious M, et al. Exome sequencing identifies a significant variant in methionyl-tRNA synthetase (MARS) in a family with late-onset CMT2. J Neurol Neurosurg Psychiatry. 2013;84(11):1247\u20139.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"2828_CR12","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/jns.12193","volume":"21","author":"M Hirano","year":"2016","unstructured":"Hirano M, Oka N, Hashiguchi A, Ueno S, Sakamoto H, Takashima H, et al. Histopathological features of a patient with Charcot-Marie-Tooth disease type 2U\/AD-CMTax-MARS. J Peripher Nerv Syst. 2016;21(4):370\u20134.","journal-title":"J Peripher Nerv Syst"},{"issue":"6","key":"2828_CR13","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1001\/archneur.1968.00470360041003","volume":"18","author":"PJ Dyck","year":"1968","unstructured":"Dyck PJ, Lambert EH. Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. II. Neurologic, genetic, and electrophysiologic findings in various neuronal degenerations. Arch Neurol. 1968;18(6):619\u201325.","journal-title":"Arch Neurol"},{"issue":"6","key":"2828_CR14","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1001\/archneur.1968.00470360025002","volume":"18","author":"PJ Dyck","year":"1968","unstructured":"Dyck PJ, Lambert EH. Lower motor and primary sensory neuron diseases with peroneal muscular atrophy. I. Neurologic, genetic, and electrophysiologic findings in hereditary polyneuropathies. Arch Neurol. 1968;18(6):603\u201318.","journal-title":"Arch Neurol"},{"key":"2828_CR15","unstructured":"Bird TD. Charcot-Marie-Tooth (CMT) Hereditary Neuropathy Overview: NCBI; [Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1358\/. Accessed 20 April 2021."},{"key":"2828_CR16","unstructured":"Online Mendelian Inheritance in Man, OMIM (TM) [Available from: http:\/\/www.ncbi.nlm.nih.gov\/omim\/. Accessed 15 April 2021."},{"issue":"23","key":"2828_CR17","first-page":"4036","volume":"27","author":"MAJ Weterman","year":"2018","unstructured":"Weterman MAJ, Kuo M, Kenter SB, Gordillo S, Karjosukarso DW, Takase R, et al. Hypermorphic and hypomorphic AARS alleles in patients with CMT2N expand clinical and molecular heterogeneities. Hum Mol Genet. 2018;27(23):4036\u201350.","journal-title":"Hum Mol Genet"},{"issue":"10","key":"2828_CR18","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1007\/s00439-020-02199-3","volume":"139","author":"PD Stenson","year":"2020","unstructured":"Stenson PD, Mort M, Ball EV, Chapman M, Evans K, Azevedo L, et al. The Human Gene Mutation Database (HGMD((R))): optimizing its use in a clinical diagnostic or research setting. Hum Genet. 2020;139(10):1197\u2013207.","journal-title":"Hum Genet"},{"issue":"1","key":"2828_CR19","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/humu.21635","volume":"33","author":"HM McLaughlin","year":"2012","unstructured":"McLaughlin HM, Sakaguchi R, Giblin W, Program NCS, Wilson TE, Biesecker L, et al. A recurrent loss-of-function alanyl-tRNA synthetase (AARS) mutation in patients with Charcot-Marie-Tooth disease type 2N (CMT2N). Hum Mutat. 2012;33(1):244\u201353.","journal-title":"Hum Mutat"},{"issue":"7","key":"2828_CR20","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1016\/j.celrep.2015.07.023","volume":"12","author":"C Gonzaga-Jauregui","year":"2015","unstructured":"Gonzaga-Jauregui C, Harel T, Gambin T, Kousi M, Griffin LB, Francescatto L, et al. Exome Sequence Analysis Suggests that Genetic Burden Contributes to Phenotypic Variability and Complex Neuropathy. Cell Rep. 2015;12(7):1169\u201383.","journal-title":"Cell Rep"},{"issue":"1","key":"2828_CR21","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13023-016-0500-5","volume":"11","author":"P Lassuthova","year":"2016","unstructured":"Lassuthova P, Safka Brozkova D, Krutova M, Neupauerova J, Haberlova J, Mazanec R, et al. Improving diagnosis of inherited peripheral neuropathies through gene panel analysis. Orphanet J Rare Dis. 2016;11(1):118.","journal-title":"Orphanet J Rare Dis"},{"issue":"8","key":"2828_CR22","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1007\/s00415-015-7778-4","volume":"262","author":"B Bansagi","year":"2015","unstructured":"Bansagi B, Antoniadi T, Burton-Jones S, Murphy SM, McHugh J, Alexander M, et al. Genotype\/phenotype correlations in AARS-related neuropathy in a cohort of patients from the United Kingdom and Ireland. J Neurol. 2015;262(8):1899\u2013908.","journal-title":"J Neurol"},{"issue":"10","key":"2828_CR23","doi-asserted-by":"publisher","first-page":"e021632","DOI":"10.1136\/bmjopen-2018-021632","volume":"8","author":"J Bacquet","year":"2018","unstructured":"Bacquet J, Stojkovic T, Boyer A, Martini N, Audic F, Chabrol B, et al. Molecular diagnosis of inherited peripheral neuropathies by targeted next-generation sequencing: molecular spectrum delineation. BMJ Open. 2018;8(10):e021632.","journal-title":"BMJ Open"},{"issue":"3","key":"2828_CR24","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1017\/S0317167100002043","volume":"29","author":"PJ Dyck","year":"2002","unstructured":"Dyck PJ, Turner DW, Davies JL, O\u2019Brien PC, Dyck PJ, Rask CA, et al. Electronic case-report forms of symptoms and impairments of peripheral neuropathy. Can J Neurol Sci. 2002;29(3):258\u201366.","journal-title":"Can J Neurol Sci"},{"issue":"14","key":"2828_CR25","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1093\/bioinformatics\/btp324","volume":"25","author":"H Li","year":"2009","unstructured":"Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25(14):1754\u201360.","journal-title":"Bioinformatics"},{"issue":"9","key":"2828_CR26","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20(9):1297\u2013303.","journal-title":"Genome Res"},{"issue":"5","key":"2828_CR27","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/ng.806","volume":"43","author":"MA DePristo","year":"2011","unstructured":"DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, Hartl C, et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet. 2011;43(5):491\u20138.","journal-title":"Nat Genet"},{"key":"2828_CR28","doi-asserted-by":"publisher","first-page":"11.0.1","DOI":"10.1002\/0471250953.bi1110s43","volume":"43","author":"GA Van der Auwera","year":"2013","unstructured":"Van der Auwera GA, Carneiro MO, Hartl C, Poplin R, Del Angel G, Levy-Moonshine A, et al. From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Curr Protoc Bioinformatics. 2013;43:11.0.1-33.","journal-title":"Curr Protoc Bioinformatics"},{"issue":"16","key":"2828_CR29","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38(16):e164.","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"2828_CR30","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1093\/bioinformatics\/btw046","volume":"32","author":"MD Vigeland","year":"2016","unstructured":"Vigeland MD, Gjotterud KS, Selmer KK. FILTUS: a desktop GUI for fast and efficient detection of disease-causing variants, including a novel autozygosity detector. Bioinformatics. 2016;32(10):1592\u20134.","journal-title":"Bioinformatics"},{"issue":"5","key":"2828_CR31","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1101\/gr.176601","volume":"11","author":"PC Ng","year":"2001","unstructured":"Ng PC, Henikoff S. Predicting deleterious amino acid substitutions. Genome Res. 2001;11(5):863\u201374.","journal-title":"Genome Res"},{"issue":"6","key":"2828_CR32","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1002\/humu.21490","volume":"32","author":"S Hicks","year":"2011","unstructured":"Hicks S, Wheeler DA, Plon SE, Kimmel M. Prediction of missense mutation functionality depends on both the algorithm and sequence alignment employed. Hum Mutat. 2011;32(6):661\u20138.","journal-title":"Hum Mutat"},{"issue":"4","key":"2828_CR33","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7(4):248\u20139.","journal-title":"Nat Methods"},{"issue":"4","key":"2828_CR34","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1016\/j.ajhg.2016.08.016","volume":"99","author":"NM Ioannidis","year":"2016","unstructured":"Ioannidis NM, Rothstein JH, Pejaver V, Middha S, McDonnell SK, Baheti S, et al. REVEL: An Ensemble Method for Predicting the Pathogenicity of Rare Missense Variants. Am J Hum Genet. 2016;99(4):877\u201385.","journal-title":"Am J Hum Genet"},{"issue":"8","key":"2828_CR35","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/nmeth0810-575","volume":"7","author":"JM Schwarz","year":"2010","unstructured":"Schwarz JM, Rodelsperger C, Schuelke M, Seelow D. MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods. 2010;7(8):575\u20136.","journal-title":"Nat Methods"},{"issue":"3","key":"2828_CR36","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1038\/ng758","volume":"29","author":"X Zhao","year":"2001","unstructured":"Zhao X, Alvarado D, Rainier S, Lemons R, Hedera P, Weber CH, et al. Mutations in a newly identified GTPase gene cause autosomal dominant hereditary spastic paraplegia. Nat Genet. 2001;29(3):326\u201331.","journal-title":"Nat Genet"},{"issue":"5","key":"2828_CR37","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1111\/j.1399-0004.2009.01184.x","volume":"75","author":"BN Smith","year":"2009","unstructured":"Smith BN, Bevan S, Vance C, Renwick P, Wilkinson P, Proukakis C, et al. Four novel SPG3A\/atlastin mutations identified in autosomal dominant hereditary spastic paraplegia kindreds with intra-familial variability in age of onset and complex phenotype. Clin Genet. 2009;75(5):485\u20139.","journal-title":"Clin Genet"},{"issue":"1","key":"2828_CR38","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.mcn.2010.08.012","volume":"46","author":"EJ Botzolakis","year":"2011","unstructured":"Botzolakis EJ, Zhao J, Gurba KN, Macdonald RL, Hedera P. The effect of HSP-causing mutations in SPG3A and NIPA1 on the assembly, trafficking, and interaction between atlastin-1 and NIPA1. Mol Cell Neurosci. 2011;46(1):122\u201335.","journal-title":"Mol Cell Neurosci"},{"key":"2828_CR39","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.mcn.2012.10.005","volume":"52","author":"J Zhao","year":"2013","unstructured":"Zhao J, Hedera P. Hereditary spastic paraplegia-causing mutations in atlastin-1 interfere with BMPRII trafficking. Mol Cell Neurosci. 2013;52:87\u201396.","journal-title":"Mol Cell Neurosci"},{"issue":"3","key":"2828_CR40","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/s12149-012-0673-5","volume":"27","author":"T Terada","year":"2013","unstructured":"Terada T, Kono S, Ouchi Y, Yoshida K, Hamaya Y, Kanaoka S, et al. SPG3A-linked hereditary spastic paraplegia associated with cerebral glucose hypometabolism. Ann Nucl Med. 2013;27(3):303\u20138.","journal-title":"Ann Nucl Med"},{"key":"2828_CR41","unstructured":"GeneCards\u00ae: The Human Gene Database [Available from: https:\/\/www.genecards.org\/. Accessed 20 October 2021."},{"issue":"3","key":"2828_CR42","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.ajhg.2014.07.013","volume":"95","author":"G Tamiya","year":"2014","unstructured":"Tamiya G, Makino S, Hayashi M, Abe A, Numakura C, Ueki M, et al. A mutation of COX6A1 causes a recessive axonal or mixed form of Charcot-Marie-Tooth disease. Am J Hum Genet. 2014;95(3):294\u2013300.","journal-title":"Am J Hum Genet"},{"issue":"1","key":"2828_CR43","doi-asserted-by":"publisher","first-page":"5045","DOI":"10.1038\/s41467-019-12909-9","volume":"10","author":"S Bervoets","year":"2019","unstructured":"Bervoets S, Wei N, Erfurth ML, Yusein-Myashkova S, Ermanoska B, Mateiu L, et al. Transcriptional dysregulation by a nucleus-localized aminoacyl-tRNA synthetase associated with Charcot-Marie-Tooth neuropathy. Nat Commun. 2019;10(1):5045.","journal-title":"Nat Commun"},{"key":"2828_CR44","doi-asserted-by":"publisher","first-page":"iv","DOI":"10.1111\/ane.12013","volume":"193","author":"GJ Braathen","year":"2012","unstructured":"Braathen GJ. Genetic epidemiology of Charcot-Marie-Tooth disease. Acta Neurol Scand Suppl. 2012;193:iv\u201322.","journal-title":"Acta Neurol Scand Suppl"},{"issue":"20","key":"2828_CR45","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1212\/WNL.0000000000001583","volume":"84","author":"WW Motley","year":"2015","unstructured":"Motley WW, Griffin LB, Mademan I, Baets J, De Vriendt E, De Jonghe P, et al. A novel AARS mutation in a family with dominant myeloneuropathy. Neurology. 2015;84(20):2040\u20137.","journal-title":"Neurology"},{"issue":"21","key":"2828_CR46","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1212\/WNL.0b013e3182574f8f","volume":"78","author":"Z Zhao","year":"2012","unstructured":"Zhao Z, Hashiguchi A, Hu J, Sakiyama Y, Okamoto Y, Tokunaga S, et al. Alanyl-tRNA synthetase mutation in a family with dominant distal hereditary motor neuropathy. Neurology. 2012;78(21):1644\u20139.","journal-title":"Neurology"},{"issue":"1","key":"2828_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejmg.2018.04.003","volume":"62","author":"S Vaeth","year":"2019","unstructured":"Vaeth S, Christensen R, Duno M, Lildballe DL, Thorsen K, Vissing J, et al. Genetic analysis of Charcot-Marie-Tooth disease in Denmark and the implementation of a next generation sequencing platform. Eur J Med Genet. 2019;62(1):1\u20138.","journal-title":"Eur J Med Genet"},{"issue":"1","key":"2828_CR48","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1111\/j.1468-1331.2010.03037.x","volume":"18","author":"GJ Braathen","year":"2011","unstructured":"Braathen GJ, Sand JC, Lobato A, Hoyer H, Russell MB. Genetic epidemiology of Charcot-Marie-Tooth in the general population. Eur J Neurol. 2011;18(1):39\u201348.","journal-title":"Eur J Neurol"},{"key":"2828_CR49","doi-asserted-by":"publisher","first-page":"769","DOI":"10.3389\/fnins.2018.00769","volume":"12","author":"RW Burgess","year":"2018","unstructured":"Burgess RW, Crish SD. Editorial: Axonopathy in Neurodegenerative Disease. Front Neurosci. 2018;12:769.","journal-title":"Front Neurosci"},{"issue":"10","key":"2828_CR50","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/S1474-4422(13)70158-3","volume":"12","author":"D Pareyson","year":"2013","unstructured":"Pareyson D, Piscosquito G, Moroni I, Salsano E, Zeviani M. Peripheral neuropathy in mitochondrial disorders. Lancet Neurol. 2013;12(10):1011\u201324.","journal-title":"Lancet Neurol"},{"key":"2828_CR51","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neulet.2015.04.001","volume":"596","author":"D Pareyson","year":"2015","unstructured":"Pareyson D, Saveri P, Sagnelli A, Piscosquito G. Mitochondrial dynamics and inherited peripheral nerve diseases. Neurosci Lett. 2015;596:66\u201377.","journal-title":"Neurosci Lett"},{"key":"2828_CR52","doi-asserted-by":"publisher","first-page":"111194","DOI":"10.1016\/j.mad.2019.111194","volume":"185","author":"Y Aman","year":"2020","unstructured":"Aman Y, Frank J, Lautrup SH, Matysek A, Niu Z, Yang G, et al. The NAD(+)-mitophagy axis in healthy longevity and in artificial intelligence-based clinical applications. Mech Ageing Dev. 2020;185:111194.","journal-title":"Mech Ageing Dev"},{"issue":"4","key":"2828_CR53","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1002\/glia.22899","volume":"64","author":"R Martini","year":"2016","unstructured":"Martini R, Willison H. Neuroinflammation in the peripheral nerve: Cause, modulator, or bystander in peripheral neuropathies? Glia. 2016;64(4):475\u201386.","journal-title":"Glia"},{"issue":"12","key":"2828_CR54","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1089\/ars.2014.6200","volume":"22","author":"AD Cherry","year":"2015","unstructured":"Cherry AD, Piantadosi CA. Regulation of mitochondrial biogenesis and its intersection with inflammatory responses. Antioxid Redox Signal. 2015;22(12):965\u201376.","journal-title":"Antioxid Redox Signal"},{"key":"2828_CR55","doi-asserted-by":"publisher","unstructured":"Jennings MJ, Kagiava A, Vendredy L, Spaulding EL, Stavrou M, Hathazi D, et al. NCAM1 and GDF15 are biomarkers of Charcot-Marie-Tooth disease in patients and mice. Brain. 2022:awac055. https:\/\/doi.org\/10.1093\/brain\/awac055.","DOI":"10.1093\/brain\/awac055"},{"issue":"D1","key":"2828_CR56","doi-asserted-by":"publisher","first-page":"D442","DOI":"10.1093\/nar\/gky1106","volume":"47","author":"Y Perez-Riverol","year":"2019","unstructured":"Perez-Riverol Y, Csordas A, Bai J, Bernal-Llinares M, Hewapathirana S, Kundu DJ, et al. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res. 2019;47(D1):D442\u201350.","journal-title":"Nucleic Acids Res"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-02828-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-022-02828-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-022-02828-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,15]],"date-time":"2022-08-15T09:05:31Z","timestamp":1660554331000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/s12883-022-02828-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,15]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2828"],"URL":"https:\/\/doi.org\/10.1186\/s12883-022-02828-6","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,15]]},"assertion":[{"value":"14 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent for research,permission to obtain clinical data from hospital records and publication were obtained from all participants. All controls agreed to research and samples taken. The control samples were anonymized. The study was submitted to the Norwegian regional committee for medical and health research ethics (REK) #2018\/982\/REK North but the need for approval was waived. The study was approved by the data protection officer at Telemark Hospital Trust. All procedures were conducted in accordance to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"299"}}